Compound ID | 3321
Class: Antimicrobial peptide
| Agent Type: | Natural product; Small molecule; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, and Enterococcus faecalis |
| Description: | Natural product from Streptomyces karnatakensis; fails to protect mice from Staphylococcus aureus infection; also shows activity in cancer cells in vitro; a depsipeptide |
| Institute where first reported: | Eli Lilly and Company |
| Year first mentioned: | 1988 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6449925 |
| Citation: | https://www.jstage.jst.go.jp/article/antibiotics1968/41/6/41_6_726/_article/-char/en |